Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Dose-finding Pilot Study of Various Formulations of Glucose-lowering Products in Otherwise Healthy Individuals With Impaired Glucose Tolerance

NCT01468376 is registered in ClinicalTrials.gov with Afexa Life Sciences Inc as lead sponsor.

NCT NCT01468376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01468376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Dose-finding Pilot Study of Various Formulations of Glucose-lowering Products in Otherwise Healthy Individuals With Impaired Glucose Tolerance
Lead sponsor
Afexa Life Sciences Inc
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2011
Completion date
January 31, 2012
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired glucose tolerance